Santen Pharmaceutical Co (MEX:4536N) Cyclically Adjusted Book per Share: MXN135.97 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4536N Santen Pharmaceutical Co Ltd MEX:4536N
88 GF Score
Price MXN339.23
GF Value MXN296.23
View Full Analysis

What is Santen Pharmaceutical Co Cyclically Adjusted Book per Share?

Santen Pharmaceutical Co MEX:4536N 88 Cyclically Adjusted Book per Share is MXN135.97 as of Jun. 2026. GuruFocus rates MEX:4536N with a GF Score™ of 88/100 and a GF Value™ of MXN296.23.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Santen Pharmaceutical Co's adjusted book value per share for the three months ended in Jun. 2026 was MXN101.306. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN135.97 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Santen Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 3.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Santen Pharmaceutical Co was 8.50% per year. The lowest was 6.50% per year. And the median was 8.10% per year.

As of today (2026-08-13), Santen Pharmaceutical Co's current stock price is MXN339.23. Santen Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was MXN135.97. Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 2.49.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Santen Pharmaceutical Co was 4.36. The lowest was 1.43. And the median was 2.38.


Santen Pharmaceutical Co  (MEX:4536N) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=339.23/135.97
=2.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Santen Pharmaceutical Co was 4.36. The lowest was 1.43. And the median was 2.38.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Santen Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Santen Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Santen Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santen Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Santen Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 176.37 209.71 168.00 194.26 160.12

Santen Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 168.79 171.44 175.25 160.12 135.97

MEX:4536N vs LLY, JNJ, ABBV: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santen Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


MEX:4536N
88GF Score
Santen Pharmaceutical Co Ltd MEX:4536N
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Santen Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Santen Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=101.306/113.6000*113.6000
=101.306

Current CPI (Jun. 2026) = 113.6000.

Santen Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 116.973 98.000 135.593
201612 110.810 98.400 127.927
201703 104.735 98.100 121.283
201706 104.242 98.500 120.222
201709 108.892 98.800 125.204
201712 119.546 99.400 136.624
201803 120.358 99.200 137.829
201806 126.174 99.200 144.490
201809 124.161 99.900 141.188
201812 127.726 99.700 145.533
201903 127.207 99.700 144.942
201906 128.361 99.800 146.110
201909 135.049 100.100 153.262
201912 130.883 100.500 147.943
202003 165.136 100.300 187.033
202006 164.430 99.900 186.979
202009 165.502 99.900 188.198
202012 151.183 99.300 172.955
202103 145.891 99.900 165.898
202106 140.898 99.500 160.864
202109 149.207 100.100 169.330
202112 144.854 100.100 164.390
202203 141.578 101.100 159.083
202206 131.218 101.800 146.428
202209 112.217 103.100 123.646
202212 113.395 104.100 123.743
202303 105.565 104.400 114.868
202306 98.660 105.200 106.538
202309 98.620 106.200 105.492
202312 96.965 106.800 103.139
202403 93.344 107.200 98.917
202406 100.075 108.200 105.070
202409 114.000 108.900 118.920
202412 112.820 110.700 115.776
202503 115.088 111.100 117.678
202506 108.943 111.700 110.796
202509 104.940 112.000 106.439
202512 101.738 113.000 102.278
202603 104.918 112.700 105.756
202606 101.306 113.600 101.306

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN135.97 mean?
Santen Pharmaceutical Co (MEX:4536N) has a Cyclically Adjusted Book per Share of MXN135.97 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Santen Pharmaceutical Co and its competitors.
Is Santen Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Santen Pharmaceutical Co's current Cyclically Adjusted Book per Share is MXN135.97. Overall, Santen Pharmaceutical Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Santen Pharmaceutical Co's Cyclically Adjusted Book per Share compare to LLY and JNJ?
Santen Pharmaceutical Co's Cyclically Adjusted Book per Share of MXN135.97 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Santen Pharmaceutical Co and its competitors. Santen Pharmaceutical Co's current Cyclically Adjusted Book per Share is MXN135.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Santen Pharmaceutical Co stock overvalued right now?
Santen Pharmaceutical Co (MEX:4536N) has a current Cyclically Adjusted Book per Share of MXN135.97. The stock's GF Value™ is MXN296.23, compared to a current price of MXN339.23 — trading 14.5% above its estimated fair value. The current Cyclically Adjusted Book per Share is MXN135.97. Santen Pharmaceutical Co's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Santen Pharmaceutical Co (MEX:4536N), the current Cyclically Adjusted Book per Share is MXN135.97 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Santen Pharmaceutical Co (MEX:4536N) Overvalued in 2026?

Based on GuruFocus' analysis, Santen Pharmaceutical Co stock appears to be overvalued. The current stock price of MXN339.23 is trading 14.5% above its estimated GF Value™ of MXN296.23.

Key valuation signals for MEX:4536N:

  • Cyclically Adjusted Book per Share: MXN135.97
  • GF Value™: MXN296.23 vs. price of MXN339.23 (14.5% above fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the MEX:4536N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Santen Pharmaceutical Co Business Description

Other Exchanges SNPHY:USA4536:Japan
Address 4-20 Ofukacho, Grand Front Osaka Tower A, Kita-ku, Osaka Prefecture, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company provides a wide range of prescription and over-the-counter eye care products, including treatments for glaucoma, dry eye, and allergies. It also develops surgical and diagnostic devices related to eye care.
88GF Score

Get the complete analysis for MEX:4536N

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN339.23
Price
MXN296.23
GF Value